
© 2024 ARIVA.de
Realtime | Geld | Brief | Zeit |
---|---|---|---|
431,75 | 432,85 | 16:44 | |
431,30 | 432,80 | 16:45 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | Vertex Pharmaceuticals' Q1 2025 Earnings: What to Expect | ||
Mi | Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday | ||
Di | Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts | ||
Mo | ToolGen Files Patent Infringement Lawsuit Against Vertex Pharmaceuticals in the United Kingdom | ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025... ► Artikel lesen | |
11.04. | Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? |